Tech Center 1600 • Art Units: 1600 1613 1614 1625
This examiner grants 25% of resolved cases
Yong Sok Kwon is an examiner in Tech Center 1600, specifically in Art Unit 1600. He has handled 61 resolved cases to date. The allowance rate is 24.6 percent, which is quite low and indicates a very challenging examination environment. Practitioners should be prepared for a rigorous process and a high likelihood of rejection. The 24.6 percent rate suggests that only a small portion of applications reach a grant under this examiner's review.
The interview lift is 42.7 percent, which is a significant positive indicator. This suggests that interviews are a very effective tool for overcoming rejections and moving a case toward an allowance. The median time to allowance is 1313 days. This is a long prosecution timeline, which is consistent with the low allowance rate. However, the 42.7 percent lift provides a critical strategic insight: an interview can substantially improve the odds of success. Practitioners should plan for an interview as a primary strategy to leverage this lift and potentially navigate the 1313 days of median pendency more effectively. The data shows that while the examiner is tough, he is responsive to direct engagement.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17792604 | HERBICIDE COMPOSITIONS WITH AUXIN HERBICIDE MONOETHANOLAMINE SALTS WITH IMPROVED PROPERTIES | Final Rejection | MONSANTO TECHNOLOGY LLC |
| 18134203 | USE OF [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2-YL)ETHYL] CARBAMATE IN COMBINATION THERAPY | Non-Final OA | SK BIOPHARMACEUTICALS CO., LTD. |
| 17640253 | NOVEL COMPOSITIONS | Final Rejection | DSM IP ASSETS B.V. |
| 17642595 | PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAME | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18390923 | MIDAZOLAM AND KETAMINE FOR ENHANCED SEDATION | Non-Final OA | Harrow IP, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy